Liminatus Pharma (LIMN) Retained Earnings (2024 - 2026)
Liminatus Pharma (LIMN) posted Retained Earnings of -$40.0 million for Q1 2026, down 2.89% sequentially from -$38.9 million in Q4 2025, and down 3773055.38% YoY from N/an in Q1 2025.
Liminatus Pharma (LIMN) Retained Earnings (2024 - 2026) Analysis & Trends
Liminatus Pharma has reported Retained Earnings for 3 years, with the latest figure at -$40.0 million in Q1 2026.
- Quarterly Retained Earnings fell 3773055.38% year-over-year to -$40.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.0 million (down 3773055.38% YoY) and the FY2025 annual result came in at -$38.9 million, down 35.61% from the prior year.
- Retained Earnings eased to -$40.0 million in Q1 2026 per LIMN's latest filing, from -$38.9 million in the prior quarter.
- Over five years, Retained Earnings peaked at $20.1 million in Q2 2025 and troughed at -$40.0 million in Q1 2026.
- A 3-year average of -$19.7 million and a median of -$29.7 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings slumped 35.61% in 2025, then plunged 3773055.38% in 2026.
- Over 3 years, Retained Earnings stood at -$28.7 million in 2024, then tumbled by 35.61% to -$38.9 million in 2025, then fell by 2.89% to -$40.0 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$40.0 million, -$38.9 million, and -$30.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 4.38 Bn |
| 10 | Liminatus Pharma | 261.83 Mn | 261.83 Mn | - | 41.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.00 Mn |
| Dec 31, 2025 | -38.87 Mn |
| Sep 30, 2025 | -30.70 Mn |
| Jun 30, 2025 | 20.07 Mn |
| Mar 31, 2025 | -1,060.00 |
| Dec 31, 2024 | -28.67 Mn |